Bone Targeting Agents in Patients with Metastatic Prostate Cancer: State of the Art

SIMPLE SUMMARY: Over the disease course of metastatic prostate cancer, approximately the 90% of patients develops bone metastases, with bone involvement frequently leading to various skeletal complications including pathological fractures, spinal cord compression, and pain. Notably enough, the pecul...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Main Authors: Mollica, Veronica, Rizzo, Alessandro, Rosellini, Matteo, Marchetti, Andrea, Ricci, Angela Dalia, Cimadamore, Alessia, Scarpelli, Marina, Bonucci, Chiara, Andrini, Elisa, Errani, Costantino, Santoni, Matteo, Montironi, Rodolfo, Massari, Francesco
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Review
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7867059/
https://ncbi.nlm.nih.gov/pubmed/33535541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13030546
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares